Crestwood Advisors Group LLC Profound Medical Corp. Transaction History

Crestwood Advisors Group LLC

  • $5.07 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$3.18 - $10.91 $13,356 - $45,822
-4,200 Reduced 18.5%
18,500 $201,000
Q3 2022

Oct 26, 2022
BUY
$3.99 - $9.3 $19,950 - $46,500
5,000 Added 28.25%
22,700 $92,000
Q2 2022

Jul 07, 2022
BUY
$6.34 - $9.53 $112,218 - $168,681
17,700 New
17,700 $129,000

Others Institutions Holding PROF

# of Institutions
45
Shares Held
8.93M
Call Options Held
1.2K
Put Options Held
5K
View Full List

About Profound Medical Corp.

PROF Quotes by TradingView
  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email